Structure of HKU4 3CLpro bound to non-covalent inhibitor 1A
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
Structure of HKU4 3CLpro bound to non-covalent inhibitor 1A
应用场景：
创建时间：
2024-02-28
相关数据集
HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound.
HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound. Descriptor: NS3 protease/helicase, Ns4a peptide, ZINC ION, ... Authors: Bogen, S, Saksena, A.K, Arasappan, A, Gu, H, Njoroge, F.G,
Protein Data Bank Japan2024-02-14 更新40
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
NIAID Data Ecosystem20
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with amprenavir at pH 6.0
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with amprenavir at pH 6.0
NIAID Data Ecosystem20
Modeling the Structure–Activity Relationship of Arbidol Derivatives and Other SARS-CoV‑2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein
Umifenovir (Arbidol) has been reported to exhibit some degree of efficacy in multiple clinical trials for the treatment of COVID-19 as a monotherapy. It has also demonstrated synergistic inhibition of
Figshare2021-12-13 更新40
Computational design and evaluation of low-toxicity saquinavir analogues targeting the catalytic dyad and oxyanion-hole loop of SARS-CoV-2 Mpro: insights from ensemble docking, molecular dynamics, dynamic undocking, and ADMET analysis
A myriad of therapeutic candidates targeting SARS-CoV-2 have entered clinical trials; however, the ongoing challenges in SARS-CoV-2 drug discovery, such as adverse effects associated with some therape
NIAID Data Ecosystem20
